Barclays Maintains an 'Overweight' on Health Care REIT (HCN); September Quarter Review - After the Call

November 8, 2011 2:09 PM EST
Get Alerts HCN Hot Sheet
Price: $52.22 -4.01%

Rating Summary:
    5 Buy, 16 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Barclays maintains an 'Overweight' on Health Care REIT (NYSE: HCN) price target of $55.00.

Barclays analyst says, "HCN reported FFO per share of $0.89, above our estimate of $0.87. Same-store NOI growth was strong at 4.2%, and was led by 8.2% same store growth in the senior living operating portfolio...NOI growth in the quarter provided visibility into the benefit of the RIDEA investments that the company has made over the last year. HCN has been acquisitive over the last year but it appears that the pipeline for further investment remains open for the company as it added to the already sizable amount of acquisitions completed thus far in 2011 with a total of $4.5 billion of gross investments made year to date."

For an analyst ratings summary and ratings history on Health Care REIT click here. For more ratings news on Health Care REIT click here.

Shares of Health Care REIT closed at $50.24 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

Barclays